Radiotherapy Market Projected Growth to 2031
Analysis based on 6 articles · First reported Jun 03, 2026 · Last updated Jun 15, 2026
The projected growth of the radiotherapy market to USD 10.68 billion by 2031 indicates a positive outlook for companies like Siemens — Siemens Healthineers, Elekta, and Accuray. Increased investments in healthcare in emerging economies such as Brazil, India, and China will drive demand for advanced radiotherapy technologies, leading to potential revenue growth for market participants.
The global radiotherapy market is projected to grow from USD 7.98 billion in 2026 to USD 10.68 billion by 2031, at a CAGR of 6.0%, according to MarketsandMarkets. This growth is driven by rising cancer incidence, increasing healthcare investments, and the growing demand for precision oncology treatments. Advanced technologies like proton beam therapy, adaptive radiotherapy, and AI-based treatment planning are transforming cancer care. The systems segment is expected to lead the market, with external beam radiotherapy dominating by technology and application. The Asia Pacific region, including China, India, South Korea, Taiwan, and Singapore, is projected to witness the highest CAGR due to increasing cancer prevalence, aging demographics, and improving healthcare infrastructure. Key companies in this market include Siemens — Siemens Healthineers, Elekta, Accuray, International Boxing Association, ViewRay, Perspective Therapeutics, Hitachi, Sumitomo Heavy Industries, Carl Zeiss Meditec, and Philips.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard